RS56380B1 - Postupak za detektovanje kancera grlića materice prouzrokovanog humanim papiloma virusom (hpv) - Google Patents

Postupak za detektovanje kancera grlića materice prouzrokovanog humanim papiloma virusom (hpv)

Info

Publication number
RS56380B1
RS56380B1 RS20170925A RSP20170925A RS56380B1 RS 56380 B1 RS56380 B1 RS 56380B1 RS 20170925 A RS20170925 A RS 20170925A RS P20170925 A RSP20170925 A RS P20170925A RS 56380 B1 RS56380 B1 RS 56380B1
Authority
RS
Serbia
Prior art keywords
cervical cancer
detect hpv
induced cervical
induced
hpv
Prior art date
Application number
RS20170925A
Other languages
English (en)
Inventor
Petrus Josephus Ferdinandus Snijders
Renske Daniëla Maria Steenbergen
Daniëlle Anne Marie Heideman
Christophorus Joannes Lambertus Maria Meijer
Original Assignee
Self Screen Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Self Screen Bv filed Critical Self Screen Bv
Publication of RS56380B1 publication Critical patent/RS56380B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/178Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
RS20170925A 2011-09-15 2012-09-13 Postupak za detektovanje kancera grlića materice prouzrokovanog humanim papiloma virusom (hpv) RS56380B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11181492 2011-09-15
EP12783347.3A EP2756099B1 (en) 2011-09-15 2012-09-13 Method to detect HPV-induced cervical cancer
PCT/NL2012/050645 WO2013039394A1 (en) 2011-09-15 2012-09-13 Methylation analysis on self-samples as triage tool for hpv-positive women

Publications (1)

Publication Number Publication Date
RS56380B1 true RS56380B1 (sr) 2017-12-29

Family

ID=47144020

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20170925A RS56380B1 (sr) 2011-09-15 2012-09-13 Postupak za detektovanje kancera grlića materice prouzrokovanog humanim papiloma virusom (hpv)

Country Status (18)

Country Link
US (1) US20150225796A1 (sr)
EP (1) EP2756099B1 (sr)
JP (1) JP6328051B2 (sr)
CN (1) CN104053783A (sr)
AU (1) AU2012309226B2 (sr)
CA (1) CA2848654C (sr)
CY (1) CY1119570T1 (sr)
DK (1) DK2756099T3 (sr)
ES (1) ES2641093T3 (sr)
HK (1) HK1198774A1 (sr)
HR (1) HRP20171411T1 (sr)
HU (1) HUE034556T2 (sr)
LT (1) LT2756099T (sr)
PL (1) PL2756099T3 (sr)
PT (1) PT2756099T (sr)
RS (1) RS56380B1 (sr)
SI (1) SI2756099T1 (sr)
WO (1) WO2013039394A1 (sr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104870653A (zh) 2012-10-12 2015-08-26 塞尔夫斯库林有限公司 用于hpv诱导的浸润性癌症及其高度前期病变的分子诊断标志物prdm14和fam19a4
EP2757161A1 (en) * 2013-01-17 2014-07-23 Splicos miRNA-124 as a biomarker of viral infection
JP2016201999A (ja) * 2013-08-26 2016-12-08 北海道公立大学法人 札幌医科大学 大腸癌を検出する方法
JP6607444B2 (ja) * 2014-02-04 2019-11-20 公立大学法人横浜市立大学 子宮頸がんの前がん病変の進行を予測するための方法
EP2974729A1 (en) 2014-07-17 2016-01-20 Abivax Quinoline derivatives for use in the treatment of inflammatory diseases
CN113564250A (zh) * 2014-10-17 2021-10-29 科罗拉多大学董事会法人团体 头颈部癌症的生物标志物及其使用方法
EP3135768A1 (en) * 2015-08-26 2017-03-01 Self-screen B.V. Zic1 and ghsr, molecular diagnostic markers for hpv-induced invasive cancers, nonhpv-induced gynaecological and anogenital cancers and their high-grade precursor lesions
SG10202106932YA (en) * 2017-03-10 2021-08-30 Self Screen Bv A methylation classifier for detection of hpv-induced invasive cancers, nonhpv- induced gynaecological and anogenital cancers and their high-grade precursor lesions
JP7218887B2 (ja) * 2017-06-29 2023-02-07 学校法人藤田学園 子宮頸がん検査用検体
WO2019063097A1 (en) * 2017-09-29 2019-04-04 Oncgnostics Gmbh DETERMINATION OF THE RISK OF NEOPLASIA AND CANCER
CN107760788B (zh) * 2017-12-05 2021-03-02 武汉艾米森生命科技有限公司 一种检测宫颈细胞基因甲基化的核酸组合及试剂盒与应用
WO2020013693A1 (en) * 2018-07-11 2020-01-16 Stichting Vumc Urine dna methylation markers for bladder cancer
CN114214415A (zh) * 2021-12-29 2022-03-22 广州安必平医药科技股份有限公司 一种用于宫颈癌相关基因甲基化检测的引物探针组合及其应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8361714B2 (en) * 2007-09-14 2013-01-29 Asuragen, Inc. Micrornas differentially expressed in cervical cancer and uses thereof
AU2009224093A1 (en) * 2008-03-13 2009-09-17 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg Cervical screening algorithms
PT2283154E (pt) * 2008-04-14 2013-08-29 Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg Diagnóstico molecular para cancros cervicais invasivos induzidos por hpv e as suas lesões precursoras de alto grau

Also Published As

Publication number Publication date
HRP20171411T1 (hr) 2017-11-17
PT2756099T (pt) 2017-09-26
EP2756099B1 (en) 2017-06-28
DK2756099T3 (en) 2017-10-02
JP2014526907A (ja) 2014-10-09
JP6328051B2 (ja) 2018-05-30
ES2641093T3 (es) 2017-11-07
SI2756099T1 (sl) 2017-11-30
WO2013039394A1 (en) 2013-03-21
LT2756099T (lt) 2017-10-10
CA2848654C (en) 2021-07-20
CN104053783A (zh) 2014-09-17
US20150225796A1 (en) 2015-08-13
CY1119570T1 (el) 2018-03-07
HUE034556T2 (en) 2018-02-28
EP2756099A1 (en) 2014-07-23
HK1198774A1 (en) 2015-06-05
CA2848654A1 (en) 2013-03-21
AU2012309226A1 (en) 2014-04-03
PL2756099T3 (pl) 2017-12-29
AU2012309226B2 (en) 2017-12-14

Similar Documents

Publication Publication Date Title
HK1245491A1 (zh) 計算機可讀介質
PL2756099T3 (pl) Sposób wykrywania wywoływanego przez HPV raka szyjki macicy
EP2855745A4 (en) METHODS RELATING TO ADALIMUM AB
SG11201400846PA (en) Adjustable fracturing system
HK1200464A1 (en) Immunobinders directed against tnf tnf
EP2714073A4 (en) ANTI-CANCER ANTIGEN GENE VACCINE IN SITU
EP2932375A4 (en) ADAPTATION OF OPPORTUNITY IN CONTEXT
EP2726628A4 (en) METHODS OF DETECTING GENE FUSIONS
IL231043A0 (en) vaccine
GB201117538D0 (en) Methods
GB201410312D0 (en) Photobioreactor
GB201118302D0 (en) Improvements to tyres
GB201119999D0 (en) Vaccine
SG10201605531PA (en) Reconstitution methods
EP2763699A4 (en) VACCINE
EP2771453A4 (en) DIATOM-BASED VACCINES
EP2854851A4 (en) METHODS ASSOCIATED WITH TRASTUZUMAB
EP2856158A4 (en) PROCEDURE RELATED TO RITUXIMAB
ZA201307669B (en) Recovery of monomers
EP2768941A4 (en) photobioreactor
GB201120000D0 (en) Vaccine
EP2691846A4 (en) USE OF METADATA
IL229109A0 (en) Cancer diagnosis
GB201107549D0 (en) Cancer vaccine
HUP1200473A2 (en) Method for enhancing commercial efficiency